Suppr超能文献

通过被动和主动免疫鉴定出的鼠疫耶尔森菌V抗原中有助于预防鼠疫的区域。

Regions of Yersinia pestis V antigen that contribute to protection against plague identified by passive and active immunization.

作者信息

Hill J, Leary S E, Griffin K F, Williamson E D, Titball R W

机构信息

Microbiology, CBD Porton Down, Salisbury, Wiltshire, United Kingdom.

出版信息

Infect Immun. 1997 Nov;65(11):4476-82. doi: 10.1128/iai.65.11.4476-4482.1997.

Abstract

V antigen of Yersinia pestis is a multifunctional protein that has been implicated as a protective antigen, a virulence factor, and a regulatory protein. A series of V-antigen truncates expressed as glutathione S-transferase (GST) fusion proteins (GST-V truncates) have been cloned and purified to support immunogenicity and functionality studies of V antigen. Immunization studies with GST-V truncates have identified two regions of V antigen that confer protection against Y. pestis 9B (a fully virulent human pneumonic plague isolate) in a mouse model for plague. A minor protective region is located from amino acids 2 to 135 (region I), and a major protective region is found between amino acids 135 and 275 (region II). In addition, analysis of IgG titers following immunization suggested that the major antigenic region of V antigen is located between amino acids 135 and 245. A panel of monoclonal antibodies raised against recombinant V antigen was characterized by Western blotting against GST-V truncates, and epitopes of most of the monoclonal antibodies were mapped to region I or II. Monoclonal antibody 7.3, which recognizes an epitope in region II, passively protected mice against challenge with 12 median lethal doses of Y. pestis GB, indicating that region II encodes a protective epitope. This is the first report of a V-antigen-specific monoclonal antibody that will protect mice against a fully virulent strain of Y. pestis. The combined approach of passive and active immunization has therefore confirmed the importance of the central region of the protein for protection and also identified a previously unknown protective region at the N terminus of V antigen.

摘要

鼠疫耶尔森菌的V抗原是一种多功能蛋白,被认为是一种保护性抗原、一种毒力因子和一种调节蛋白。一系列作为谷胱甘肽S-转移酶(GST)融合蛋白表达的V抗原截短体(GST-V截短体)已被克隆和纯化,以支持V抗原的免疫原性和功能研究。用GST-V截短体进行的免疫研究已确定V抗原的两个区域在鼠疫小鼠模型中可提供针对鼠疫耶尔森菌9B(一种完全有毒力的人类肺鼠疫分离株)的保护作用。一个较小的保护区域位于氨基酸2至135之间(区域I),一个主要保护区域位于氨基酸135至275之间(区域II)。此外,免疫后IgG滴度分析表明,V抗原的主要抗原区域位于氨基酸135至245之间。通过针对GST-V截短体的蛋白质印迹法对一组针对重组V抗原产生的单克隆抗体进行了表征,并且大多数单克隆抗体的表位被定位到区域I或II。识别区域II中一个表位的单克隆抗体7.3被动保护小鼠免受12个半数致死剂量的鼠疫耶尔森菌GB的攻击,表明区域II编码一个保护性表位。这是关于一种V抗原特异性单克隆抗体可保护小鼠免受完全有毒力的鼠疫耶尔森菌菌株攻击的首次报道。因此,被动和主动免疫相结合的方法证实了该蛋白中心区域对保护的重要性,并且还在V抗原的N末端鉴定出一个先前未知的保护区域。

相似文献

2
Development of a multiple-antigen protein fusion vaccine candidate that confers protection against Bacillus anthracis and Yersinia pestis.
PLoS Negl Trop Dis. 2019 Aug 20;13(8):e0007644. doi: 10.1371/journal.pntd.0007644. eCollection 2019 Aug.
3
Active immunization with recombinant V antigen from Yersinia pestis protects mice against plague.
Infect Immun. 1995 Aug;63(8):2854-8. doi: 10.1128/iai.63.8.2854-2858.1995.
9
Small protective fragments of the Yersinia pestis V antigen.
Vaccine. 2009 May 11;27(21):2775-80. doi: 10.1016/j.vaccine.2009.03.011. Epub 2009 Mar 13.

引用本文的文献

1
Nanolipoprotein particle (NLP) vaccine confers protection against aerosol challenge in a BALB/c mouse model.
Front Immunol. 2025 Jun 26;16:1603710. doi: 10.3389/fimmu.2025.1603710. eCollection 2025.
3
Evaluation of human antibodies from vaccinated volunteers for protection against infection.
Microbiol Spectr. 2024 Oct 3;12(10):e0105424. doi: 10.1128/spectrum.01054-24. Epub 2024 Aug 27.
4
Towards a Yersinia pestis lipid A recreated in an Escherichia coli scaffold genome.
Access Microbiol. 2024 Jul 17;6(7). doi: 10.1099/acmi.0.000723.v3. eCollection 2024.
6
Sex differences in immune protection in mice conferred by heterologous vaccines for pneumonic plague.
Front Immunol. 2024 May 21;15:1397579. doi: 10.3389/fimmu.2024.1397579. eCollection 2024.
7
Functional assays to screen and select monoclonal antibodies that target .
Hum Vaccin Immunother. 2023 Aug 1;19(2):2216085. doi: 10.1080/21645515.2023.2216085. Epub 2023 Jun 8.
9
Host-Pathogen Interactions of Marine Gram-Positive Bacteria.
Biology (Basel). 2022 Sep 5;11(9):1316. doi: 10.3390/biology11091316.
10
Potential human immunotherapeutics for plague.
Immunother Adv. 2021 Oct 5;1(1):ltab020. doi: 10.1093/immadv/ltab020. eCollection 2021 Jan.

本文引用的文献

1
BIOSYNTHESIS AND PURIFICATION OF V AND W ANTIGEN IN PASTEURELLA PESTIS.
J Immunol. 1963 Aug;91:179-84. doi: 10.21236/ad0299868.
3
Yersinia pestis--etiologic agent of plague.
Clin Microbiol Rev. 1997 Jan;10(1):35-66. doi: 10.1128/CMR.10.1.35.
4
V antigen-polyhistidine fusion peptide: binding to LcrH and active immunity against plague.
Infect Immun. 1996 Oct;64(10):4313-8. doi: 10.1128/iai.64.10.4313-4318.1996.
5
A new improved sub-unit vaccine for plague: the basis of protection.
FEMS Immunol Med Microbiol. 1995 Dec;12(3-4):223-30. doi: 10.1111/j.1574-695X.1995.tb00196.x.
9
Passive immunity to yersiniae mediated by anti-recombinant V antigen and protein A-V antigen fusion peptide.
Infect Immun. 1994 Oct;62(10):4192-201. doi: 10.1128/iai.62.10.4192-4201.1994.
10

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验